KOR

e-Article

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged >= 18 Years
Document Type
Journal
Source
CLINICAL INFECTIOUS DISEASES; DEC 23 2021, 9p.
Subject
Language
English
ISSN
15376591